lenalidomide

You have access
Incorporating Bortezomib in the Management of Plasmablastic Lymphoma
ONYEDIKA UMEANAETO, JOSEPH GAMBOA, JESUS DIAZ, M. NAWAR HAKIM, JAVIER CORRAL, ALEXANDER PHILIPOVSKIY and SUMIT GAUR

Anticancer Research September 2019, 39 (9) 5003-5007; DOI: https://doi.org/10.21873/anticanres.13690
You have access
Acute Renal Failure Associated with Lenalidomide Treatment in Multiple Myeloma: A Rare Occurrence?
NATALIA KREINIZ, ALI KHATEEB, SHARON GINO-MOOR, AARON POLLIACK and TAMAR TADMOR

Anticancer Research June 2016, 36 (6) 2889-2892;
You have access
Bortezomib, Thalidomide and Lenalidomide: Have They Really Changed the Outcome of Multiple Myeloma?
MICHAEL MIAN, MARTINA TINELLI, ELENA DE MARCH, GLORIA TURRI, VITTORIO MENEGHINI, NORBERT PESCOSTA, TAMARA BERNO, ALESSANDRA MARABESE, PATRIZIA MONDELLO, FRANCESCA PATRIARCA, GIOVANNI PIZZOLO, GIANPIETRO SEMENZATO, SERGIO CORTELAZZO and RENATO ZAMBELLO

Anticancer Research March 2016, 36 (3) 1059-1065;
You have access
Genes Involved in Maintaining the Bone Marrow Stroma Are Dysregulated in Patients with Myelofibrosis: Lenalidomide Treatment Up-regulates SOCS3
ANA LIVUN, KATE J. NEWBERRY, TAGHI MANSHOURI, RAJKO KUSEC and SRDAN VERSTOVSEK

Anticancer Research October 2015, 35 (10) 5219-5223;
You have access
The Preclinical Activity of Lenalidomide in Indolent Urothelial Carcinoma
WEIGUO JIAN, JONATHAN M. LEVITT, SETH P. LERNER and GURU SONPAVDE

Anticancer Research July 2014, 34 (7) 3383-3389;
You have access
Post-transplantation Consolidation and Maintenance Therapy with Lenalidomide for Japanese Patients with Multiple Myeloma
HIROYUKI TAKAMATSU, SAORI MUNEMOTO, RYOICHI MURATA, YASUSHI TERASAKI, KENICHI NAKAJIMA and SHINJI NAKAO

Anticancer Research December 2013, 33 (12) 5681-5685;

Main menu

User menu

Search

lenalidomide